CATALYST HEALTHCARE CONSULTING - Key Persons

Job Titles:

• Vice President, Communications
• Vice President, Communications and Research

Anne McNickle, Vice President, Communications and Research, is a health policy expert and strategist with over 28 years of experience spanning the biopharma industry, consulting, and journalism. Ms. McNickle specializes in regulatory strategy, policy analysis, and communications. She leads strategic research projects and analyzes policy issues and trends for biopharma and medtech clients. At Amgen, she provided strategic advice on the impact of changes to federal and state coverage and reimbursement policy to the company's Business Units and executive team. She also served in a range of strategic communications roles, working with national media and trade press and showcasing the company's scientific innovation. Earlier in her career, she held policy analyst roles at several DC-area consulting firms. She began her career in pharmaceutical/health care journalism, serving in a range of positions at FDC Reports in Washington, DC. Over the course of her tenure there, she led a staff of reporters as Managing Editor of Health News Daily; served as Capitol Hill Editor for The Pink Sheet; and covered regulatory, political, and business news affecting the biopharma industry. Ms. McNickle received her BA from the College of William and Mary.

Job Titles:

• Regulatory Policy Strategist

Betsy Foss-Campbell, MA, Regulatory Policy Strategist, is a seasoned strategy and policy advocate who has been at the forefront of driving and advancing novel regulatory policy for the cutting-edge field of regenerative medicine, specifically gene and cell therapy. She has a unique ability to identify and define challenges in the field, communicate the science, and work with diverse interests to craft policies, alliances and implement win-win strategies that help relevant government entities from FDA to NIH to Capitol Hill best serve the needs of patients and innovators. Ms. Foss-Campbell has over 28 years of professional experience spanning varied areas. She has served in senior nonprofit management roles for the past eight years, including Executive Director-level leadership, with an emphasis in scientific association management. Most recently she was the Director of Policy and Advocacy at the American Society of Gene and Cell Therapy, where she promoted the development of, and patient access to, transformative treatments. While at ASGCT, Ms. Foss-Campbell developed multiple new initiatives, including an annual FDA liaison meeting, an annual Policy Summit tackling hot policy topics, and a patient education program. She also oversaw global outreach efforts and helped launch diversity and inclusion awards. Her work has connected her with thought leaders at numerous biotechnology and pharmaceutical companies, patient advocacy organizations, and other professional societies and trade organizations in the gene and cell therapy, rare disease, and oncology spaces. Ms. Foss-Campbell's experiences include social issue/policy advocacy and 15 years of direct healthcare service, treating individuals with upper extremity trauma at an academic medical center. She received master's degrees in political science and communication from Marquette University and a BS in occupational therapy from the University of Wisconsin.

Job Titles:

• Business Manager
• Research Assistant

Ms. Hanlon, Business Manager & Research Assistant at Catalyst Healthcare Consulting, Inc., brings an extensive background in business administration. For ten years, she worked as Senior Administrative Assistant at Eli Lilly and Company in the US Regulatory Division, and prior to that she worked for the President of NABI Biomedical Research. She also served as Executive Assistant to the SVP of Strategic Marketing at Phillips Publishing Company, and for 25 years as VP and Secretary of Hanlon Construction, Inc. Ms. Hanlon received her Associates Arts Degree in Business Administration from Strayer University in Washington, DC.

Job Titles:

• Senior Vice President
• Senior Vice President, Market Access & Reimbursement Strategies
• Senior Vice President, Reimbursement Strategy and Market
• Senior Vice President, Reimbursement Strategy and Market Access

Jeff M. Myers, MBA, Senior Vice President, Reimbursement Strategy and Market Access, is an expert advisor helping clients understand and formulate successful market access and reimbursement strategies. His experience spans working for Congress, life science innovators, as well as a range of payors and providers. Over his three decades in Washington, he has built and managed communications, government relations and regulatory policy organizations that have successfully addressed complex public policy issues that cross multiple constituencies. His fluency in understanding the big picture as well as the technical expertise in nuanced reimbursement and coverage policy and politics is demonstrated by his often sought out views. He frequently is asked to serve as a keynote speaker and panelist at conferences or is a "go to" opinion leader in the healthcare media space. One of the largest growth areas in healthcare has been in the public payor space - specifically Medicaid and Medicare. As the former CEO and President of the Medicaid Health Plans of America (MHPA), Jeff was at ground zero during the massive expansion of this program and the overwhelming shift to managed care organizations (MCOs) and the resulting federal and state regulations. During his five-year tenure, his efforts with MHPA propelled the trade association to become a top influencer with government regulators, Congress and the media while representing companies taking full risk in populations as diverse as children, the working poor, and intellectually and physically disabled citizens. His deep experience was sought by the one of the largest Medicaid MCOs in the country - CareSource, based in Dayton Ohio which serves more than 1.8M members - as their EVP of Strategy and External Relations. In this role he oversaw the development of the company's future growth efforts, its structure for winning new RFPs and RFAs, and its development of policy and government relations. Mr. Myers started his career on Capitol Hill, serving several members of the US House of Representatives on both the Ways and Means and Energy and Commerce Committee. This launched his interest and background in health care as those committees considered President Clinton's Health Security Act. During this time, he authored multiple amendments and bills in the health space addressing Medicare, Medicaid and pharmaceutical issues. Notably, the FDA Export Reform and Enhancement Act, which he wrote, became law in 1996 (P.L 104-132). After leaving Congress, he worked for several different pharmaceutical companies representing them before Congress and the Administration. In this role he became a primary contact for products facing major issues for the company for whom he worked; these including managing products with significant illegal use and abuse issues, intellectual property challenges, public reimbursement impacts, and newly discovered medical side effects. He served on internal reimbursement committees. Through this effort he developed a strong understanding of political, governmental and communications crisis management. Always looking for the next challenge, Jeff joined American Health Care Association, the nation's largest trade association representing skilled nursing and assisted living facilities, as their Senior VP for Policy and Government Relations. Public payor programs (Medicaid and Medicare) have an overwhelming impact on the viability and sustainability of these providers, and he developed policy and government relations strategies which lead to increased reimbursement and appropriate governmental oversight. He has an MBA from the Fuqua School of Business, Duke University, and a BA in International Relations and Psychology from Rhodes College.

Job Titles:

• CEO
• Founder

Nancy Bradish Myers, JD, CEO of Catalyst Healthcare Consulting, Inc., is a Washington-based attorney with deep expertise in health care law and regulation, policy development and government relations. She has been closely involved in cutting edge drug, biotechnology and medtech regulatory issues from a range of vantage points over the past two and a half decades.

Job Titles:

• Scientific Communications Lead

Taryn Serman, PhD, Scientific Communications Lead, is a trained molecular biologist, science communication specialist, and budding graphic designer. She has a passion for distilling complex scientific topics into digestible, creative, and comprehensive content. Her scientific expertise includes cell biology, next-generation sequencing, and infectious disease-especially viral evolution and pathogenesis. Dr. Serman's writing portfolio includes first-author research publications in top scientific journals, highly cited review articles summarizing key studies in host-pathogen interactions, and diverse marketing content developed for use by biopharma companies. Her experience in scientific storytelling has allowed for seamless communication across a variety of audiences, from the highly technical research community to the general public. She holds a PhD in Microbiology from the University of Chicago and received her BS and Professional Science Master (PSM) degree in Biotechnology from Penn State University.